CTOs on the Move

Merus

www.merus.nl

 
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.merus.nl
  • 1 Broadway
    Cambridge, MA USA 02142
  • Phone: 781.760.0013

Executives

Name Title Contact Details
Marcin Cieslik
Director of Technology | Commercial & Medical IT | Biotech | Pharma | AI & Digital Innovation | Commercial Operations | Commercialization | New Product Launch | Global Expansion | Marketing | Veeva & Salesforce Certified Profile

Similar Companies

Western Allergy Services

Western Allergy Services Ltd is a Victoria, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CoGenesys

CoGenesys is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Turing Pharmaceuticals

Turing Pharmaceuticals is a fully integrated biopharmaceutical company focusing on patients with unmet medical needs. We are dedicated to helping patients, who often have no effective treatment options, by developing and commercializing innovative treatments.

Fischer Imaging

Manufactures programmable E/P stimulators. The Company manufactures a full line of programmable E/P stimulators to accommodate the needs of cardiologists. The Company also develops, manufactures and markets a diagnostic x-ray and digital radiography sy...

Savara Pharmaceuticals

Savara Inc. is an orphan lung disease company. Savara`s pipeline comprises: Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for PAP, and in Phase 2a development for NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of MRSA infection in cystic fibrosis. Savara`s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. Savara`s management team has significant experience in orphan drug development and pulmonary medicine, in identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.